1. Home
  2. TRS vs MDXG Comparison

TRS vs MDXG Comparison

Compare TRS & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRS
  • MDXG
  • Stock Information
  • Founded
  • TRS 1986
  • MDXG 2006
  • Country
  • TRS United States
  • MDXG United States
  • Employees
  • TRS N/A
  • MDXG N/A
  • Industry
  • TRS Industrial Specialties
  • MDXG Biotechnology: Pharmaceutical Preparations
  • Sector
  • TRS Industrials
  • MDXG Health Care
  • Exchange
  • TRS Nasdaq
  • MDXG Nasdaq
  • Market Cap
  • TRS 1.0B
  • MDXG 999.9M
  • IPO Year
  • TRS 2007
  • MDXG N/A
  • Fundamental
  • Price
  • TRS $25.68
  • MDXG $6.34
  • Analyst Decision
  • TRS Strong Buy
  • MDXG Strong Buy
  • Analyst Count
  • TRS 1
  • MDXG 2
  • Target Price
  • TRS $40.00
  • MDXG $12.50
  • AVG Volume (30 Days)
  • TRS 357.0K
  • MDXG 664.5K
  • Earning Date
  • TRS 07-29-2025
  • MDXG 07-30-2025
  • Dividend Yield
  • TRS 0.62%
  • MDXG N/A
  • EPS Growth
  • TRS N/A
  • MDXG N/A
  • EPS
  • TRS 0.77
  • MDXG 0.27
  • Revenue
  • TRS $939,580,000.00
  • MDXG $352,375,000.00
  • Revenue This Year
  • TRS $6.37
  • MDXG $9.55
  • Revenue Next Year
  • TRS $3.56
  • MDXG $11.43
  • P/E Ratio
  • TRS $33.42
  • MDXG $23.36
  • Revenue Growth
  • TRS 3.80
  • MDXG 5.34
  • 52 Week Low
  • TRS $19.33
  • MDXG $5.47
  • 52 Week High
  • TRS $28.51
  • MDXG $10.14
  • Technical
  • Relative Strength Index (RSI)
  • TRS 55.93
  • MDXG 37.98
  • Support Level
  • TRS $25.59
  • MDXG $6.30
  • Resistance Level
  • TRS $26.50
  • MDXG $6.51
  • Average True Range (ATR)
  • TRS 0.68
  • MDXG 0.19
  • MACD
  • TRS -0.10
  • MDXG -0.04
  • Stochastic Oscillator
  • TRS 55.02
  • MDXG 4.26

About TRS TriMas Corporation

TriMas Corp designs, develops and manufactures a diverse set of products primarily for the consumer products, aerospace & defense, and industrial markets . The company operates through three segments namely: The packaging segment manufactures and distributes closure and dispensing systems. The aerospace segment supplies blind bolts, fasteners, rivets, and other products for the aerospace industry. The specialty product segment manufactures and distributes steel cylinders, wellhead engines, compression systems, industrial sealing, and fasteners.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: